Novasenta
Pittsburgh, United States· Est. 2018
Novasenta develops novel immunotherapies targeting the tumor microenvironment for cancer treatment.
Private Company
Total funding raised: $40M
About
Novasenta develops novel immunotherapies targeting the tumor microenvironment for cancer treatment.
AntibodiesBiologics
Funding History
1Total raised:$40M
Series A$40MOct 15, 2021